| Foam Preparations for the Treatment of Ulcerative Colitis. | |
| | |
MedLine Citation:
|
PMID: 21235478 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Patients with ulcerative colitis uniformly have disease involving the distal colon. When patients have disease limited to the left colon or symptoms suggestive of active rectal inflammation, guidelines recommend topical rectal therapies as first-line agents either as monotherapy or in conjunction with oral products. Rectal delivery modalities offer the advantage of delivering high local concentrations of active medication to the site of maximal inflammation with minimization of systemic side effects. Methods of rectal administration include suppositories, liquid enemas and foams. Suppositories are limited to the treatment of rectal disease, and patients often have difficulty retaining the liquid enema secondary to its high volume and consistency. Rectal foams reliability extend to the descending and sigmoid colon with application. Foams are further characterized by increased viscosity, lower volumes, finer dispersion on the colonic mucosa, and increased adhesiveness to the colonic mucosa compared with liquid enemas. Additionally, rectal foam agents demonstrate equal efficacy to their liquid enema counterparts yet consistently yield better patient tolerance, lower incidence of side effects, and increased patient acceptability. Currently available agents include 5-aminosalicylic acid and corticosteroids, both first and newer generation. This review focuses on clinical trials assessing efficacy, tolerability, and patient preferences for these agents as well as describing the currently available rectal foam products. |
| | |
Authors:
|
Burr J Loew; Corey A Siegel |
Related Documents
:
|
10205218 - Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. 20143468 - Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in... 9766818 - Influence of transjugular intrahepatic portosystemic shunts (tips) on tissue oxygenatio... 9605268 - Predictive factors influencing the therapeutic response to diuretic treatment of ascite... 794418 - Dermatitis herpetiformis: immunoelectronmicroscopic and ultrastructural studies of a pa... 158448 - Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients w... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-14 |
Journal Detail:
|
Title: Current drug delivery Volume: - ISSN: 1875-5704 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101208455 Medline TA: Curr Drug Deliv Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, NH 03756, Lebanon. corey.a.siegel@hitchcock.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessment of short-term changes induced by a Dermatophagoides pteronyssinus extract on asthmatic pa...
Next Document: Characterization and In vitro Evaluation of Intestinal Absorption of Liposomes Encapsulating Zanamiv...